The formation of scar tissue in response to damage is the story of the repair cell of con nective tissue-the fibroblast (Fig. 1) . The quiescent fibroblast or fibrocyte is a cell of low metabolic activity which in the normal situ ation is virtually inactive. This 'hibernating' cell is found in low numbers throughout con nective tissue with its highest density around blood vessels. Following a wound, poly morphs enter the area of damage and clot within a few minutes becoming established in large numbers within hours. One of their prin cipal roles is to digest clot material. Mono nuclear cells become established in substantial numbers later; the time is variable but by 48 hours they would be in large numbers in most "normal" wound healing processes. The macrophages phagocytose debris and dying polymorphs. Only after the cleaning up process is well established do fibroblasts become prominent. Phar macological control of the fibroblast depends on an understanding of the processes of importance in its life history at the wound site. For the purpose of this presentation the stages in the life history of the fibroblast during tissue repair have been divided into Of course, these processes often occur con currently at the wound site but it is convenient to treat them separately.
Stimulation and Migration
The fibrocyte, on activation into a fibroblast, is stimulated via its surface membrane recep tor system to migrate. Migratory stimuli are classified into three main types; haptotactic, chemokinetic and chemotactic.
Haptotaxis is the directional movement of cells along a solid which has become impreg nated with an attractant. If cultured scleral fibroblasts are seeded down onto a flask or petri dish which has been coated with strands of vitreal (Type 2) collagen, initially the settle ment is random. Within a few hours fibro blasts become preferentially aggregated along the collagen strands (Fig. 2) . Time lapse cine photomicrography shows that the fibroblasts migrate along the strands, more or less in the same direction. The fibroblasts, as they move, lay down a trail of glycoprotein attractants which stimulate other fibroblasts to follow the same path thus establishing a "track of preference" .1
If skin fibroblasts are injected into the rab bit vitreous, the same process can be seen to take place in vivo with fibroblasts migrating along the collapsed vitreal gel towards the optic nerve head or the ora serrata. 2 Chemokinetic stimuli induce fibroblasts to migrate but not in a directional manner whereas chemotactic stimuli cause fibroblasts to migrate down a concentration gradient. These substances are usually in solution or in suspension and their chemoattraction can be measured in vitro in a variety of ways, one of which is the Boyden chamber. 3 In the Boyden chamber or modified Boyden, the stimulant is placed on one side of a porous membrane and fibroblasts are placed on the other. The pores are large enough for the fibroblasts to pass through from one side to the other. A positive chemoattractant induces significantly more fibroblasts to traverse the membrane than a control solution. Figure 3 shows the dose response curve for a solution of fibronectin. Fibronectin strands can be seen in one comer of the phase CUl1lrast micrograph (small arrows). Fibroblasts can be seen aggregated on a particularly large fibronectin strand (large arrows). These fibroblasts are elongated and time lapse shows the cells moving in a unidirectional manner (x500).
Fibronectin is produced in both soluble and chemotactic factors include collagen frag insoluble forms at the site ot wound healing by ments. fragments of elastin. platelet derived severai cell types including fibroblasts. To growth factor. interleukins. leukotriene, the determine whether we are dealing with chemC5a of the complement cascade. fibroblast okinesis or chemotaxis a chequerboard analyconditioned medium. epithelial conditioned sis is needed.' An array is established so that medium and even ATP. As can be appreci there are different concentrations of ated. they are for the most part products of attractant on both sides of the membrane. damaged tissue. substances which would be Chemokinesis is shown by the diagonal across produced by proliferating cells at the site of a the chequerboard where concentrations of wound or the products of inflammatory the attractant are the same on either side of mononuclear cells. It was once thought that the membrane. Chemotaxis requires the polymorphs were responsible for attracting attractant to be on the opposite side of the fibroblasts into a wound but lymphocytes and, membrane from the cells i. e. the first vertical particularly, macrophages are now concolumn (Fig. 4) . It can be seen (Fig. 4) receptor system on the surface membrane of the fibroblasts so that the chemoattractant sig nals fail to elicit a response. While the third is to compromise the locomotory system of the fibroblast so that even although there are sig nals present and the signals can get through, the cells are too sluggish to respond. Obviously, anti-inflammatory drugs such as corticosteroids will help to reduce the chem oattractant stimuli at the wound site because they will reduce the influx of inflammatory cells into the wound and macrophages and lymphocytes produce potent chemoattrac tants for fibroblasts. Chemicals which can neutralise chemoattractants include such unlikely materials as actin. Actin has an avid affinity for fibronectin which is produced in copious amounts in and around a wound. When actin binds to fibronectin it impairs the chemotactic, chemokinetic and haptotactic activity of the latter. This is not just a test-tube phenomenon because injections of actin at a site of injury have been shown to impede seriously the normal fibroblastic response.
There are, undoubtedly, receptors on the surface of fibroblasts through which the sig nals for enhanced migration function. Total or specific receptor blockade represents an intriguing and potentially valuable means of fibroblast control. Receptor blockade, because it does not necessarily result in cell death, is not handicapped by the secondary inflammation which complicates some of the other forms of fibroblast control (see later). However, in an ocular context, receptor blockade remains a possibility to be evaluated in the laboratory rather than a practical method for modifying scar tissue formation in the patient.
However drugs, which modify the cell cytoskeleton and therefore depress the fibro blast's ability to migrate, show current prom ise. Colchicine inhibits microtubule assembly and as such can retard fibroblast locomotion. Oral colchicine was recently shown to decrease scar formation in the rabbit's vitreous7 and the results were sufficiently encouraging to justify a trial investigation of the effectiveness of the drug on patients with proliferative vitreoretinopathy (PYR). The fibroblasts are given the opportunity to migrate from the upper to lower wells through a permeable membrane. It can be seen that the fibroblasts migrate both to a concentration gradient (vertical column one, where there is fibronectin in the lower well but not in the upper) i. e. chemotaxis and in the absence of a gradient (diagonal where the con centration offibronectin is equal in both chambers) i. e.
chemokinesis.
Division
It is a little fatuous to separate migration and division into separate categories. Prolifera tion can be considered to be the combined effects of migration and division and, for that matter, most growth factors not only promote mitosis but are also chemotactic. Exogenous growth factors regulate the division cycle of fibroblasts. Some stimulate the fibrocyte to come out of its GO stage while others exert their influence at the G1 stage prior to DNA synthesis. Growth factors do not seem to influence the division cycle thereafter from DNA synthesis (S) through G1 into mitosis (M) but on returning to G 1, growth factors are required to push the cell through the division cycle once again. It is not clear where and how all the various growth promoting substances exert their effect on the fibroblast cycle, but platelet derived growth factor activates proto oncogenes (genes which control growth) in the fibroblast as it emerges from quiescence and epidermal growth factor decreases the time the cell spends in G 1. 8 On the other side of the coin, some prostaglandins can down regulate fibroblast growth, the inhibition being related to increased amounts of intra cellular cyclic AMP and, in addition, inter feron has an antiproliferative effect by prolonging the time the fibroblast spends in GOIG 1 and G2.9 Fibroblasts are relatively late arrivals at the site of a wound, they reach optimal numbers within one to two weeks,1O plateau and then slowly decrease in numbers over a protracted period extending up to several months.u Table I shows a list of medications which have been used to control fibroblast numbers in scar tissue formation. It is by no means com prehensive but each of the drugs listed has been used in an ocular context either in clini cal or experimental studies. Mononuclear cells are a major source of growth promoting and inhibiting substances which are effective on fibroblasts. Therefore steroids which dampen down the inflammation reduce the amount of 'stimulator' at the wound and retard fibroblast growth. There is good in vitro evidence that corticosteroids have a direct influence on fibroblast proliferation and sup press their normal growth curve on the culture plateY Elevated histamine levels in culture can suppress the stimulated fibroblast growth curves and these compounds may, potentially, serve as useful fibroblast modulators in the clinical situation. 13 Of the various antimetabolites, 5-fluo rouracil has been popular in an ocular context to decrease the numbers of fibroblasts within scar tissue. 5-fluorouracil is a synthetic pyrimidine which inhibits the formation of thymidine and so has its maximal influence on DNA synthesis (S phase) but also has some effect on RNA synthesis. Gressel et al. 14 and Kay and co-workersl5 have used 5-fluorouracil to control scar formation following experi mental aqueous drainage surgery. Following the success of experimental studies, Heuer et al.1 6 have used the drug in a pilot study to prevent fibrous collapse of drainage blebs in patients with a poor drainage surgical prog nosis. Both experimentaP7 and clinicaP8 evi dence suggests that antineoplastic agents like 5-fluorouracil can reduce the amount of fibrous reproliferation in the vitreous follow ing vitrectomy procedures for the treatment of complex retinal detachment.
The antibiotic daunomycin has been used as an antitumour agent because it binds and blocks DNA function and also causes chain scission through generation of free radicals in the immediate vicinity of the DNA molecule. Inhibition of fibroblast growth with this anti neoplastic agent has been shown within the eyel9 and in the culture f1ask. 20 The vinca alkaloids like colchicine not only inhibit fibroblast locomotion (see previous section) but also arrest the cell division cycle by their well known action on the micro tubules of the metaphase spindle. Without an intact spindle the chromosomes are dispersed in the cytoplasm which ultimately leads to cell death.
The disadvantage of many of the drugs listed in Table I , is their general tissue toxicity which is quite a problem for scar tissue control in and around such a delicate and vulnerable structure as the eye. For some time now, research in one area of tumour cell killing has centred on the magic bullet principle in an attempt to introduce selectivity. The idea is to target drugs down onto the specific cell to be killed while leaving others untouched and in this way far lower concentrations of cytocidal agents are needed (Table II) . The targeting Recently some of the problem has been over come by introducing an acid sensitive spacer between the antibody and the antibiotic. 21 The spacer is unaffected by normal pH out side the cell but when internalised into the target cell the low pH of the lysosomal system cleaves the spacer molecule and the antibiotic 'bullet" is released to do its work.
Perhaps the most popular 'bullet' is ricin, partly because it takes only one molecule to kill a cell and partly because of its molecular structure. The ricin molecule consists of two polypeptides: one is the active killing arm and the other adheres to cell surfaces. If the non specific adhering polypeptide is replaced by the selective antibody then the killing arm can be targeted selectively to the cell of choice.22
Several alternative molecular combinations have been studied involving ricin, parts of the ricin molecule and other toxins.
Selective killing of fibroblasts, the subjects of this presentation, is in its infancy but may be an important future development for the control of ocular scarring. Fibroblasts have been selectively killed in vitro, usually as a tissue culture device to rid the culture of fibro blasts and so preserve another less vigorous cell type. We have illustrated the mechanism with two examples from our laboratory where polyclonal antibodies have been used to target and complement has been used as the bullet (Fig. 5) . In the first example (Fig. 5a ) the test cultures have been treated with antifibronec tin antibodies and complement. As we know, fibroblasts produce copious amounts of fi bro nectin and some of the fibronectin links inti mately with the cell membrane. Therefore some of the antibody to fibronectin will be at the fibroblast cell surface and the fibroblasts are vulnerable to complement lysis. It can be seen that the killing is inefficient because, although the cells do not thrive when com pared to a normal growth curve, it still takes 7 days to eliminate the fibroblast population. In Fig. 5b we have used a polyclonal antibody to fibroblast cell membrane which is consider ably more effective, there being virtually no cells left after 1. 5 days exposure to the anti. body and complement. /.
. --. The triangles show the normal growth curve whereas the circles show that the fibroblast population is virtually lost one day later when exposed to a polyclonal anti fibroblast surface membrane antibody and complement.
Contraction
At one time it was considered that the con traction which resulted in the closure of a gaping wound was brought about by the short ening of collagen. It is true that collagen shrinkage can take place in the test tube but this is at nonphysiologically high tempera tures. It is now considered that wound con traction is a cellular rather than an extracellular event; the cell responsible for the generation of the contractile force being the fibroblast. 2 3 Gabbiani and colleagues put forward the concept of the 'myofibroblast' as the con tractile stage in the life history of the fibroblast in a wound or in granulation tissue. Their idea was that fibroblasts which looked something like smooth muscle cells also became lined up and acted like muscle cells to contract scar tissue and bring about wound closure.23. 2 4 On the face of it their evidence was reasonable. Among the evidence put forward was that the electron microscopic features of some fibro blasts were not that of cells with abundant rough endoplasmic reticulum in their cytoplasm ( Fig. 6a and b) but, instead, they were elongated, had indented nuclei and they had aggregates of cytoplasmic action micro filaments ( Fig.6c and d) . These elongated spindle shaped cells were defi ned as myo fibroblasts. In addition, immunofluorescent staining showed cells with abundant smooth muscle elements in early wounds and bio chemically substantial amounts of actin were isolated from wounds and granulation tissue when they were known to be at a contractile stage of scar tissue development. Perhaps one of the most interesting pieces of evidence was that strips of granulation tissue were respon sive to pharmacological manipulation in an organ bath in much the same way that was done routinely with strips of smooth muscle tissue (see later).
The case for fibroblast activity being responsible for the contraction of scars is not in doubt but the concept of the fibroblast being or even acting as a smooth muscle cell may not be correct. It is thought more likely that wound closure and contraction of gran ulation tissue is brought about by the migra tion of fibroblasts into the injury site. Fibroblasts, when they migrate, in contrast to other mobile cells e.g. macrophages, generate extremely strong tractional forces in the sub strate on which they move. A remarkable demonstration of these forces was shown by Harris who grew fibroblasts and other cells on gossamer sheets of silicone. These extremely thin layers of silicone became distorted by traction lines as fibroblasts moved over them whereas macrophages hardly produced a rip ple on the surface. 2 5 In other experiments, 26 segments of tissue (explants) were placed on a collagenous gel and when the fibroblasts migr ated out of the explants the collagen in the gel became distorted, the fibres were realigned parallel to the axis connecting adjacent explants and the gel contracted. Their obser vations were consistent with the idea that the migratory fibroblasts were exerting a physical pull on the substratum. This pull was not just a simple muscle-like contraction of the fibro blasts-instead of pulling the substratum by shortening their length the cells exert a shear ing force by their own forward propUlsion. The tractional force which develops is analogo us to that exerted by a car's tyre on the road. Imagine a baby trying to crawl on I I carpet which rests on a highly polished floor. As the baby tries to move the carpet starts to crumple and the more vigorous the baby's efforts the more ruffled and folded the carpet becomes.
The migratory fibroblast is continually altering its points of attachment to the loose temporary scaffold of clot, glycoprotein and collagen in the wound site. Traction results in the dragging in of these materials. Lewis27 compared the fibroblast drag to the action of sailors pulling ropes because they haul in the rope by a hand-over-hand action with the pos ition of the hands on the rope continually altering. Time-lapse measurements of mobile retinal pigment epithelium (which have fibra-blast-like characteristics) pulling on collagen threads have shown a hauling in rate of around 2 flm per minute.28 Our own data (Fig. 7) shows scleral fibroblasts can drag in strands of fibronectin at approximately 2 flm per hour. These experiments are in no way comparable so the difference in rate is not meaningful. The two studies merely illustrate the 'reeling in' ability of mobile cells. If mobile fibroblasts, rather than the so called myofibroblasts, are responsible for gen erating the isotonic forces necessary to close wounds then what is the role of the elongated spindle shaped myofibroblasts? A clue to their role in scar tissue can be obtained from their ultrastructural features. These cells produce an extracellular matrix material called myo fibroblast associated substance (MAS), they have junctions between adjacent cells, they have extensions sometimes referred to as microtendons and the actin microfilaments are organised into distinctive stress fibre aggregates ( Fig. 6a and b) . 29 The presence of stress fibres provides a clue to the function of the myofibroblast because stress fibres are seen in abundance in cells in tissue culture and also in cells like vascular endothelium in vivo and are thought to be associated with seden tary behaviour. Cells with well developed stress fibres are considered to be strongly adherent to their substrata.
Kreis and Birchmeier30 showed that fibro blast stress fibres are contractile. However their function would seem to be to maintain tension so that cells with prominent stress fibres generate isometric rather than isotonic force. Thus the myofibroblast is like a cellular staple holding the contracted scar tissue in position until, later, it becomes cocooned in collagen and the tissue is stabilised. All the ultrastructural features described earlier e.g. junctions, MAS, microtendons are consistent with an isometric role. Therefore, we prefer to call these cells spindle fibroblasts, which is merely descriptive, rather than myo fibroblasts, which assumes a function which may not be true.
The nest building activities of the Indian leaf ant have several parallels which help with the concepts we have outlined. These ants build a nest by bending a leaf over in half and then sealing the edges together to make a chamber. Initially the ants scurry all over the leaf and eventually bend the leaf over. As the edges come close together a number of ants hold one edge in their mandibles and the other by their back legs. These volunteers carry out the same function as the myofibroblast by holding the tension in the system (isometric). Unfortunately their fate is somewhat similar to the myofibroblasts because they end up cocooned, not in collagen but in silk.
Irrespective of the precise details, scar tissue contraction and the initial maintenance of the contracted state is cell dependent. Con trol of these contractile events requires us, if possible, to be able to influence the muscular and skeletal apparatus within the cytoplasm of the fibroblast. For example Trocinate, a powerful smooth muscle antagonist, was shown by Madden and co-workers3] to inhibit the normal contraction of the scar tissue which formed in full-thickness dorsal skin wounds. In a separate study of skin wound healing, contraction was impaired by the vinca alkaloids colchicine and vinblastin but sur prisingly, not by cytochalasin B. 32 As mentioned earlier, strips of scar tissue in an organ bath contract to electrical and phar macological stimuli but interestingly the scar strips also were capable of drug-induced relaxation. One study on intravitreal scars demonstrated contraction to serotonin, angiotensin, bradykinin and relaxation with papaverine, cytochalasin B, diphenhy dramine and diltiazemY Another in vitro procedure for monitoring the contractile force generated by fibroblasts is the single cell contraction assay. For this, cultured fibroblasts are permeabilised with either glyceroP4 or detergent35 and then exposed to ATP. The decrease in fibroblast surface area associated with the ATP-induced contraction can be measured manually or by image analysis. Under the circumstances of this assay, fibroblasts produce their optimum contraction with 0.1 mM ATP and their response of 30% contraction is not far short of aortic smooth muscle cells subjected to the same evaluation (unpublished results from our own laboratory).
The single cell contraction assay provides an opportunity to evaluate drugs which might usefully counteract the isotonic and isometric forces generated by fibroblasts in scar tissue, and to investigate the fundamental mecha nisms which influence the behaviour of con tractile elements within fibroblasts. Not surprisingly, the contraction of fibroblasts is calcium dependent;35 also cytochalasin B, tri fluoperazine and alkaline phosphatase are effective blockers of ATP-induced con traction.36 In addition it has been shown that single cell fibroblast contraction can be supressed by preincubation with prosta glandin E 2 , cholera toxin and cyclic AMP.36 lt is known that elevated prostaglandin E 2 results in elevated cyclic AMP so that we are probably dealing with a common mechanism and it is hypothesised that contraction is inhibited because elevated cyclic AMP leads to the reduction of myosin ATPase and the consequent inhibition of cytoplasmic micro filament activity.
Whether or not many of the in vitro relax ants are as effective in vivo remains to be determined. We know that cytochalasin B which is so effective in vitro (see earlier) is disappointing when it comes to treating experimental wounds in rabbits.3 2 Trocinate has had encouraging effects on wounding but, in general the control of wound healing by modulating scar contraction remains an exciting but theoretical possibility. Developments in this area will be hampered whilst we still do not fully understand the underlying mecha nisms involved in scar contraction.
Synthesis
The fibroblast produces the extracellular materials which are the structural components of the scar tissue at the site of a wound (Fig. 1) . In wound healing the main com ponents are collagens type 1 and 3 but, in addition, the fibroblast synthesises glycosaminoglycans, glycoproteins and elastic elements (Fig. 8) . It is no wonder that the ultrastructural appearance of many of the fibroblasts during wound healing, is not as the myofibroblast described in the earlier section, but of a synthesising cell rich in rough endo plasmic reticulum ( Fig. 6c and d) . Usually the synthesising fibroblast has a well developed Golgi apparatus, many coated pits and vesi cles, compact mitochondria with dense matrices and abundant lysosomes. It should be remembered that fibroblasts, as well as being proficient at synthesising extracellular materials, are equally adept at dissolving matrix substances by the release of enzymes such as collagenase. For that matter a process of remodelling continues within scar tissue long after the bulk of the scar has been estab lished with localised dissolution and resynthesis of collagen taking place.
During wound healing the maximum pro duction of glycoproteins precedes that of col lagenY The principal glycoprotein formed at this time is fibronectin which adheres avidly to the fibrin clot. Since fibroblasts do not adhere particularly well to fibrin and fibronectin is the ideal substrate for fibroblasts (see earlier sec tion) then it is more than probable that the insoluble fibrin-fibronectin complex serves as the temporary scaffold for the initial waves of fibroblast invasion.38 Fibronectin which is so abundant in an early wound is virtually absent from the mature scar.
Glycosaminoglycan formation peaks at about the same time as collagen production. These materials do not just fill the space between collagen fibres but have an intimate relationship with the collagen units. It has been shown that tissue which develops with a small diameter collagen fibril is rich in hyaluronic acid whereas those with a large diameter collagen fibril contain high con centrations of dermatan sulphate. The sugges tion is that the growth of fibril diameter beyond 60 nm in diameter is inhibited by the presence of excess hyaluronic acid. 39 Of the various forms of collagen (there are at least 12), types 1 and 3 are of particular interest in scar formation. Collagen produc tion takes place in two stages, an intracellular and an extracellular stage. The backbone of all collagen molecules are triple stranded chains which form a regular helix. Each poly peptide strand (alpha chain) consists of approximately 1,000 amino acids and there are seven distinct types which have been iden tified. The polypeptide strands are produced on ribosomes and from there they pass into the lumina of rough endoplasmic reticulum. These pro-alpha-chains have, in addition to the alpha chain, a signal peptide needed for passing the chain into the rough endoplasmic reticulum and extension peptides for guiding triple helix formation. Alpha chains are rich in proline and glycine and some of these residues are hydroxylated in the endoplasmic reticulum before the chains form the triple helix of the procollagen molecules. The pro collagen molecules are glycosylated and pack aged with other macromolecules (extension peptides may be involved in the packaging process). The extension peptides are cleaved off the procollagen by peptidases during the subsequent secretion stage and this results in the formation of tropocollagen.
Outside the fibroblast the tropocollagen molecules align into microfibrils which sub sequently bundle together to form collagen microfibrils. The tensile strength of collagen is enhanced by the many cross-links between the tropocollagen molecules in each microfibril. Cross-linkage starts by the oxidation to aldehyde of some of the terminal amino groups of lysines, hydrolysines or glycosylated hydroxylysine under the control of the enzyme lysyl oxidase. Then the aldehydes create links either by aldol condensation (aldehyde to aldehyde) or Schiff-base linkage (aldehyde to lysine, hydrolysine, etc). The aldol condensations and Schiff-base linkages develop slowly and can take many months or even years to complete. Indeed, the Schiff base links are thought not be be stable and firmer cross-links are established over an extended period of time.
It was once considered that elastic fibres did not develop during wound healing. However, elastin is produced in wounds (Fig. 8) but the fibres tend to be small and they develop late on in the healing process. 40 Little is known about the accumulation of elastic precursors following wounding but, interestingly, Alex ander41 noted a massive build-up of oxytalan fibres in old corneal scars. Oxytalan is thought to be a component of the elastic fibre system consisting of fibrils but no elastin.
Clearly control of extracellular matrix development is as important an area of attack as any of the others we have outlined in this publication. In practice most attempts to con trol the extracellular matrix have centred on collagen since it is the main structural compo nent. Prominent among the pharmacological agents used to control scarring are colchicine, Beta-aminoproprionitrile, penicillamine and to a lesser extent the enzyme collagenase (Table III) . Colchicine has a direct effect on the fibroblasts and reduces their ability to secrete tropocollagen but also causes an increased outpouring of collagenase into the matrix. Beta-aminoproprionitrile and pen icillamine are lathyrogens. The former inhibits lysyl oxidase and so prevents the for- Peacock44 has used lathyrogens in combina tion with colchicine to prevent excessive build-up of collagen following the surgical removal of large keloids. Experimental studies in animals or trials on patients have indicated that control of extracellular matrix development by colchicine or lathyrogens may be of value in such diverse situations as treatment of alkali burns to the oesophagus, prevention of urethral strictures, tendon repair, cirrhosis, the reduction of intestinal adhesions in peritoneal healing and many others.
Weiss and Belkin45 showed that rabbits given intramuscular penicillamine developed less vitreal scar tissue following penetrating injury. Unfortunately Behrens-Baumann and Vogel46 who used penicillamine in conjunc tion with dexamethasone to control vitreal scarring did not find any encouraging results. Beta-aminoproprionitrile, on the other hand, substantially reduced scar tissue formation in the rabbit vitreous. Electron microscopy con firmed that collagen was fragmented in the diminutive scars which formed after drug therapyY This inhibitor of collagen matura tion has been used topically on filtering blebs following glaucoma surgery to reduce tensile strength and maintain drainage patency in dif ficult patients.48
Conclusion
As the complex life history of the fibroblast in wound healing becomes better understood an effective arsenal of drugs capable of control ling or killing fibroblasts has become available to us. Some are in clinical use, many are still the subjects of intensive investigation but we look forward to the time when we have an extensive and comprehensive panel of medi cations to control the development of ocular 
